The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors

<table>STS (steroid sulfatase) and SULT1E1 (estrogen sulfotransferase 1E1) in high-grade serous ovarian carcinoma. Immunoreactivity of STS and SULT1E1 is demonstrated in paraffin-embedded tissue sections from ovarian carcinoma. Sections were probed with an antibody against STS (GTX 105498, GeneTex, Irvine, CA) and SULT1E1 (NBP1-56977, Novus Biol., Littleton, CO), respectively. STS and SULT1E immunoreactivity is visible in the cancer cells (C). ST = tumor stroma, BV = blood vessel. </table>

Journal of Drug Delivery

fig4

Figure 4

Figure 4: The Sulfatase Pathway for Estrogen Formation: Targets for the Treatment and Diagnosis of Hormone-Associated Tumors 